357P Bridging the gap between real-world studies (RWSs) and randomized controlled trials (RCTs) of 1st-line palbociclib+aromatase inhibitors (P+AI) in hormone receptor-positive (HR+)/HER2-negative(-) metastatic breast cancer (mBC)
S. Nucera(Breast Cancer Research Foundation), Daniele Generali(University of Trieste), Fabiola Giudici(University of Padua), M. Cristofanilli(Cornell University), Grazia Arpino(University of Naples Federico II), M. Lambertini(University of Genoa), Paolo Vigneri(Humanitas University), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Massimo Milani(University of Padua), H.S. Rugo(UCSF Helen Diller Family Comprehensive Cancer Center), Richard Tancredi(Istituti Ospitalieri di Cremona), Carla Strina(Istituti Ospitalieri di Cremona), B. Conte(Breast Cancer Research Foundation), G. Curigliano(European Institute of Oncology), T. Pascual(Hospital Clínic de Barcelona), Mariateresa Giuliano(University of Naples Federico II), L. Del Mastro(Ospedale Policlinico San Martino), A. Gennari(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), C. Criscitiello(European Institute of Oncology), F. Schettini(Breast Cancer Research Foundation)
Cited by 0
Related Papers
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
|Cancer Research|2009|298
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
|JNCI Journal of the National Cancer Institute|2018|282
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282